Aureus Asset Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$229K Hold
1,022
0.02% 207
2025
Q4
$246K Hold
1,022
0.02% 173
2025
Q3
$280K Hold
1,022
0.02% 167
2025
Q2
$264K Hold
1,022
0.02% 173
2025
Q1
$229K Hold
1,022
0.02% 187
2024
Q4
$234K Hold
1,022
0.02% 190
2024
Q3
$249K Buy
+1,022
New +$228K 0.02% 179
2024
Q2
Sell
-1,022
Closed -$202K 211
2024
Q1
$202K Buy
+1,022
New +$187K 0.01% 190
2021
Q1
Sell
-961
Closed -$204K 195
2020
Q4
$204K Buy
+961
New +$192K 0.02% 179

Other funds holding RMD

Aureus Asset Management's RMD Position: Q1 2026 in Review

Aureus Asset Management held its ResMed (RMD) position steady in Q1 2026 at 1,022 shares worth $229K. The position accounts for 0.02% of the portfolio, ranked #207.

Aureus Asset Management first reported a position in RMD in Q4 2020 and has held it in 9 quarters since. The position peaked at $280K in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Aureus Asset Management held 1,022 shares of ResMed worth $229K as of Q1 2026.
  • Aureus Asset Management left its ResMed share count unchanged in Q1 2026.
  • ResMed made up 0.02% of Aureus Asset Management's portfolio in Q1 2026, its #207 holding.
  • Aureus Asset Management first reported a position in ResMed in Q4 2020 and has held it in 9 quarters since.
  • Aureus Asset Management's ResMed position peaked at $280K in Q3 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Aureus Asset Management's 13F filing for Q1 2026, filed 13 May 2026.